A new in vitro lipid digestion – in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations
- 811 Downloads
In vitro lipid digestion models are commonly used to screen lipid-based formulations (LBF), but in vitro-in vivo correlations are in some cases unsuccessful. Here we enhance the scope of the lipid digestion test by incorporating an absorption ‘sink’ into the experimental model.
An in vitro model of lipid digestion was coupled directly to a single pass in situ intestinal perfusion experiment in an anaesthetised rat. The model allowed simultaneous real-time analysis of the digestion and absorption of LBFs of fenofibrate and was employed to evaluate the influence of formulation digestion, supersaturation and precipitation on drug absorption.
Formulations containing higher quantities of co-solvent and surfactant resulted in higher supersaturation and more rapid drug precipitation in vitro when compared to those containing higher quantities of lipid. In contrast, when the same formulations were examined using the coupled in vitro lipid digestion – in vivo absorption model, drug flux into the mesenteric vein was similar regardless of in vitro formulation performance.
For some drugs, simple in vitro lipid digestion models may underestimate the potential for absorption from LBFs. Consistent with recent in vivo studies, drug absorption for rapidly absorbed drugs such as fenofibrate may occur even when drug precipitation is apparent during in vitro digestion.
KEY WORDSabsorption drug solubilisation in situ intestinal perfusion lipid-based drug delivery systems supersaturation
Area under the curve
High performance liquid chromatography
Lipid Formulation Classification System
Ultra performance liquid chromatography – tandem mass spectrometer
ACKNOWLEDGMENTS AND DISCLOSURES
The authors would like to thank Mr Doron Gafni for drawing of the model schematic. Funding support from the Monash University Institute of Graduate Research (MIGR) is gratefully received.
- 8.Anby MU, Williams HD, McIntosh M, Benameur H, Edwards GA, Pouton CW, et al. Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems. Mol Pharm. 2012;9(7):2063–79.CrossRefPubMedGoogle Scholar
- 12.Williams HD, Sassene P, Kleberg K, Bakala-N’Goma JC, Calderone M, Jannin V, et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations. J Pharm Sci. 2012;101(9):3360–80.CrossRefPubMedGoogle Scholar
- 13.Williams HD, Anby MU, Sassene P, Kleberg K, Bakala-N’Goma J-C, Calderone M, et al. Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion. Mol Pharm. 2012;9(11):3286–300.CrossRefPubMedGoogle Scholar
- 14.Williams H, Sassene P, Kleberg K, Calderone M, Igonin A, Jule E, et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations. Pharm Res. 2013:1–18.Google Scholar
- 22.Griffin BT, Kuentz M, Vertzoni M, Kostewicz ES, Fei Y, Faisal W, et al. Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate. Eur J Pharm Biopharm. 2014;86(3):427–37.CrossRefPubMedGoogle Scholar
- 24.Dahan A, Hoffman A. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. Eur J Pharm Biopharm. 2007;67(1):96–105.CrossRefPubMedGoogle Scholar
- 25.Yeap YY, Trevaskis NL, Porter CJH. The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs. Mol Pharm. 2013.Google Scholar
- 30.Persson L, Porter CH, Charman W, Bergström CS. Computational prediction of drug solubility in lipid based formulation excipients. Pharm Res. 2013:1–13.Google Scholar
- 37.Caldwell J. The biochemical pharmacology of fenofibrate. Cardiology. 1989;76 Suppl 1:33–41.Google Scholar
- 43.Minekus M, Marteau P, Havenaar R. A multi-compartmental dynamic computer-controlled model simulating the stomach and small intestine. ATLA Altern Lab Anim. 1995;23:197–209.Google Scholar